User banner image
User avatar
  • admin

Posts

Embassy Group Launches India’s Only Integrated GCC Platform – ‘EMBARK’

A Complete Solution for Establishing and Scaling Global Capability Centers in India BENGALURU, India, March 29, 2025 /PRNewswire/ — Embassy Group, one of India’s leading...

Agentic AI and Scalable Enterprise Integration Catalyse AI Industry Growth

Top 10 AI growth opportunities to drive innovation, efficiency, and responsible AI development LONDON, March 29, 2025 /PRNewswire/ — Artificial Intelligence (AI) is set to...

Baidu’s Apollo Go Partners with Autogo in Plan to Build Abu Dhabi’s Largest Robotaxi Fleet

During the initial period, Apollo Go and Autogo will collaborate to deploy dozens of autonomous vehicles in Abu Dhabi, with phased expansion planned ahead of...

LifeTech Scientific Corporation Announced 2024 Annual Results: Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%

SHENZHEN, China, March 29, 2025 /PRNewswire/ — LifeTech Scientific Corporation (the “Company” or “LifeTech”, Stock code: 1302.HK), a company specializing in minimally invasive interventional medical devices...

K&F CONCEPT Camera Manual Cleaning Air Blower Wins iF Design Award 2025

SHENZHEN, China, March 28, 2025 (GLOBE NEWSWIRE) — Recently, K&F CONCEPT has won the iF Design Award 2025 for its Camera Manual Cleaning Air Blower,...

Tr1X Announces Succession Plan: Appoints David de Vries CEO, Effective June 1; Bill Lis to Serve as Executive Chairman

SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) — Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered Treg and CAR-Treg cell therapies...

Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare Networks

Regional Medical Leaders Embrace Daxor’s ezBVA Lab Service Oak Ridge, TN, March 28, 2025 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), Daxor, the global leader...

Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

CB1 inverse agonism is a clinically validated mechanism to induce weight loss CRB-913 is markedly more peripherally restricted compared to monlunabant and rimonabant SAD/MAD Phase...

Catheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial Results

FORT MILL, S.C., March 28, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products,...

Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851

Lexicon eligible to receive up to $1 billion in upfront and development, regulatory and sales milestone payments, including $75 million in upfront and near-term milestone...